Chunghwa Chemical Synthesis & Biotech Co Ltd Financial Flexibility Index
Chunghwa Chemical Synthesis & Biotech Co Ltd financial flexibility index. Chunghwa Chemical Synthesis & Biotech Co Ltd (1762) has a Financial Flexibility Index of 0.07x as of March 2026. Free cash flow of NT$91.86 Million (operating CF NT$90.44 Million minus capex NT$1.42 Million) represents 0% of total liabilities (NT$1.28 Billion). See free cash flow generation of Chunghwa Chemical Synthesis & Biotech Co to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Chunghwa Chemical Synthesis & Biotech Co Ltd (2008–2025)
Financial flexibility index of Chunghwa Chemical Synthesis & Biotech Co Ltd from 2008 to 2025. Historical Financial Flexibility Index trend for Chunghwa Chemical Synthesis & Biotech Co Ltd across 18 annual periods. Check 1762 cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Chunghwa Chemical Synthesis & Biotech Co Ltd Financial Flexibility Index by Year (2008–2025)
Chunghwa Chemical Synthesis & Biotech Co Ltd financial flexibility index by year from 2008 to 2025. Year-by-year free cash flow to debt coverage for Chunghwa Chemical Synthesis & Biotech Co Ltd. For the full cash flow conversion analysis, see 1762 operating cash flow.
| Year | Flexibility Index | Free Cash Flow (TWD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.17x | NT$204.94 Million | NT$142.61 Million | NT$1.23 Billion | ▼ -59.1% |
| 2024 | 0.41x | NT$572.35 Million | NT$467.65 Million | NT$1.41 Billion | ▲ +99.1% |
| 2023 | 0.20x | NT$372.49 Million | NT$-77.50 Million | NT$1.82 Billion | ▼ -74.7% |
| 2022 | 0.81x | NT$1.11 Billion | NT$733.78 Million | NT$1.37 Billion | ▲ +92.6% |
| 2021 | 0.42x | NT$624.63 Million | NT$219.18 Million | NT$1.49 Billion | ▼ -17.7% |
| 2020 | 0.51x | NT$331.22 Million | NT$138.24 Million | NT$648.48 Million | ▲ +89.9% |
| 2019 | 0.27x | NT$382.92 Million | NT$268.13 Million | NT$1.42 Billion | ▲ +1.4% |
| 2018 | 0.27x | NT$328.39 Million | NT$234.66 Million | NT$1.24 Billion | ▼ -55.3% |
| 2017 | 0.59x | NT$965.14 Million | NT$159.34 Million | NT$1.63 Billion | ▲ +50.5% |
| 2016 | 0.39x | NT$376.17 Million | NT$261.31 Million | NT$954.48 Million | ▲ +89.9% |
| 2015 | 0.21x | NT$208.98 Million | NT$79.70 Million | NT$1.01 Billion | ▲ +94.7% |
| 2014 | 0.11x | NT$169.67 Million | NT$23.08 Million | NT$1.59 Billion | ▼ -44.5% |
| 2013 | 0.19x | NT$255.28 Million | NT$145.24 Million | NT$1.33 Billion | ▼ -75.0% |
| 2012 | 0.77x | NT$1.03 Billion | NT$268.46 Million | NT$1.34 Billion | ▲ +153.7% |
| 2011 | 0.30x | NT$211.96 Million | NT$144.84 Million | NT$698.59 Million | ▼ -36.2% |
| 2010 | 0.48x | NT$327.11 Million | NT$275.61 Million | NT$687.80 Million | ▲ +6.6% |
| 2009 | 0.45x | NT$498.62 Million | NT$462.07 Million | NT$1.12 Billion | ▲ +446.2% |
| 2008 | 0.08x | NT$117.51 Million | NT$75.39 Million | NT$1.44 Billion | — |